Periodic updates from the General Thoracic Surgical Club.
GTSC Podcast
Claim This Podcastby General Thoracic Surgical Club
5.0(9 reviews)
6 episodes
Updated Weekly
Accepts GuestsHas Sponsors
Podcast Overview
Periodic updates from the General Thoracic Surgical Club.
Language
🇺🇲
Publishing Since
10/30/2023
1 verified contact email on file for GTSC Podcast
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
October 21, 2025
Lung nodule localization prior to thoracic surgery
<p data-start="378" data-end="687">In this episode of the General Thoracic Surgical Podcast, Dr. Linda Martin and Dr. Rishi Reddy explore the rapidly evolving landscape of <strong data-start="517" data-end= "545">lung nodule localization</strong>—a critical topic as thoracic surgeons increasingly encounter smaller, non-palpable nodules due to expanded screening and imaging practices.</p> <p data-start="689" data-end="1190">The conversation covers the full spectrum of localization techniques—from traditional wire and dye marking to advanced <strong data-start="808" data-end= "832">robotic bronchoscopy</strong>, <strong data-start="834" data-end="874">ICG (indocyanine green) fluorescence</strong>, and <strong data-start="880" data-end="908">molecular imaging agents</strong> such as CYTALUX® (pafolacianine) injection. The discussion highlights workflow integration, patient safety, cost considerations, and the implications of emerging <strong data-start="1072" data-end= "1098">bronchoscopic ablation</strong> and <strong data-start= "1103" data-end="1139">molecular-targeted visualization</strong> technologies on the future of thoracic oncology.</p> <p data-start="689" data-end="1190">This episode is proudly sponsored by On Target Laboratories.</p>
August 18, 2025
Changes in Early-Stage Lung Cancer Treatments Options
<p>In this podcast, Drs. Linda Martin (UVA) and Dennis Wigle (Mayo Clinic Rochester, MN) discuss key updates in the treatment of early stage surgically resectable non small cell lung cancer from the 2025 American Society of Clinical Oncology Annual Meeting. Topics include updated survival data from the CheckMate 816 trial of neoadjuvant nivolumab plus chemotherapy, the practice impact of PROSPECT lung accrual, and results from the NeoADAURA trial of neoadjuvant osimertinib. This episode was sponsored by BMS.</p>
September 18, 2024
N2 Disease - Are There Any Rules Anymore!
<p>In this podcast, Drs. Linda Martin and Jessica Donington discuss the evolving approach to treating N2 disease in stage 3 lung cancer, emphasizing the shift from therapeutic nihilism to more aggressive surgical strategies. They highlight the success of combining chemotherapy, immunotherapy, and surgery, which has led to improved outcomes, especially in patients with multi-station N2 disease, while noting the importance of rethinking traditional treatment paradigms and focusing on systemic control rather than local clearance alone.</p>
6 total episodes available
Deep-dive analytics for GTSC Podcast
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is GTSC Podcast?
- How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 6 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.